These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 37309766)

  • 1. Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.
    Kumar K; Singh N; Yadav HN; Maslov L; Jaggi AS
    Curr Cardiol Rev; 2023; 19(6):56-71. PubMed ID: 37309766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective signalling: Past, present and future.
    Jovanović A
    Eur J Pharmacol; 2018 Aug; 833():314-319. PubMed ID: 29935170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
    Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
    Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
    Sivaraman V; Yellon DM
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?
    Balakumar P; Rohilla A; Singh M
    Pharmacol Res; 2008 Jun; 57(6):403-12. PubMed ID: 18586514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide-mediated myocardial pre- and post-conditioning.
    Predmore BL; Lefer DJ
    Expert Rev Clin Pharmacol; 2011 Jan; 4(1):83-96. PubMed ID: 21373204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.
    Xiong J; Liao X; Xue FS; Yuan YJ; Wang Q; Liu JH
    Chin Med J (Engl); 2011 Jul; 124(14):2209-15. PubMed ID: 21933628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).
    Hausenloy DJ
    Curr Pharm Des; 2013; 19(25):4544-63. PubMed ID: 23270554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
    Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
    Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury.
    Saeid F; Aniseh J; Reza B; Manouchehr VS
    Eur J Prev Cardiol; 2018 Sep; 25(14):1463-1481. PubMed ID: 29442529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury.
    Wu Y; Liu H; Wang X
    Life Sci; 2021 Jan; 264():118628. PubMed ID: 33131670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
    Sanada S; Komuro I; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.
    Andreadou I; Iliodromitis EK; Koufaki M; Kremastinos DT
    Mini Rev Med Chem; 2008 Aug; 8(9):952-9. PubMed ID: 18691153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peoniflorin Preconditioning Protects Against Myocardial Ischemia/Reperfusion Injury Through Inhibiting Myocardial Apoptosis: RISK Pathway Involved.
    Ma H; Hao J; Liu H; Yin J; Qiang M; Liu M; He S; Zeng D; Liu X; Lian C; Gao Y
    Appl Biochem Biotechnol; 2022 Mar; 194(3):1149-1165. PubMed ID: 34596828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.